U.S. Residential REITs Stock News

NYSE:LNG
NYSE:LNGOil and Gas

Cheniere Energy (LNG) EPS Surge Reinforces Bullish Profitability Narratives For FY 2025

Cheniere Energy (LNG) has wrapped up FY 2025 with fourth quarter revenue of US$5.5b and basic EPS of US$10.79, against a backdrop of trailing twelve month revenue of US$20.0b and EPS of US$24.26 that puts the full year firmly in focus for investors. The company has seen revenue move from US$4.5b and EPS of US$4.35 in Q4 2024 to US$5.5b and EPS of US$10.79 in Q4 2025, while trailing net income over the last twelve months reached US$5.3b. This frames a year where profitability metrics sit at...
NYSE:GOLF
NYSE:GOLFLeisure

Acushnet Holdings (GOLF) Margin Compression Challenges Bullish Profitability Narrative Heading Into Earnings

Acushnet Holdings (GOLF) closed FY 2025 with Q4 revenue of US$477.2 million and a basic EPS loss of US$0.58, while trailing twelve month revenue stood at US$2.6 billion and TTM basic EPS was US$3.13. Over recent quarters, the company has seen quarterly revenue move from US$620.5 million and EPS of US$0.89 in Q3 2024 to US$703.4 million with EPS of US$1.62 in Q1 2025, before settling at US$657.7 million and US$0.81 in Q3 2025, which feeds into the current TTM profile investors are assessing...
NasdaqGS:FA
NasdaqGS:FAProfessional Services

First Advantage (FA) Quarterly Profitability Streak Tests Long Running Loss Narrative

First Advantage FY 2025 Earnings Snapshot First Advantage (FA) has wrapped up FY 2025 with Q4 revenue of US$420.0 million and basic EPS of US$0.02, alongside trailing 12 month revenue of about US$1.6 billion and a loss of US$34.8 million on a net income basis. The company has seen quarterly revenue move from US$199.1 million in Q3 FY 2024 to US$307.1 million in Q4 FY 2024, then to US$354.6 million in Q1 FY 2025, US$390.6 million in Q2, US$409.2 million in Q3 and US$420.0 million in Q4. Basic...
NasdaqGS:AEVA
NasdaqGS:AEVAElectronic

Aeva Technologies (AEVA) Q4 Loss Highlights Tension With High Growth And Valuation Narratives

Aeva Technologies (AEVA) has wrapped up FY 2025 with Q4 revenue of US$5.6 million and a basic EPS loss of US$0.42, alongside a full year trailing EPS loss of US$2.55 on revenue of US$18.1 million. The company has seen quarterly revenue move from US$2.7 million in Q4 2024 to US$5.6 million in Q4 2025, while basic EPS has shifted from a loss of US$0.67 to a loss of US$0.42 over the same period, with net income swinging between a loss of US$36.1 million in Q4 2024 and a loss of US$25.3 million...
NYSE:CCO
NYSE:CCOMedia

Clear Channel Outdoor (CCO) Q4 Loss Highlights Ongoing Profitability Strain Despite Revenue Scale

Clear Channel Outdoor Holdings (CCO) just closed out FY 2025 with Q4 revenue of US$461.5 million and a basic EPS loss of US$0.01, while trailing twelve month revenue sat at about US$1.6 billion and EPS at a loss of US$0.22. Over recent quarters the company has seen revenue move from US$375.2 million in Q3 2024 to US$426.7 million in Q4 2024 and then US$461.5 million in Q4 2025. Basic EPS has swung between a loss of US$0.06 in Q3 2024, a loss of US$0.00 in Q4 2024, and a loss of US$0.01 in Q4...
NYSE:QBTS
NYSE:QBTSSoftware

D Wave Quantum (QBTS) Trailing US$355 Million Loss Tests Bullish Growth Narratives

D-Wave Quantum (QBTS) has wrapped up FY 2025 with Q4 revenue of US$2.8 million, a basic EPS loss of US$0.12, and a net loss of US$42.3 million. This sets the tone for a year in which the trailing twelve months show US$24.6 million in revenue, a basic EPS loss of US$1.11, and a net loss of US$355.1 million. Over recent quarters, the company has reported quarterly revenue between US$1.9 million and US$15.0 million, while basic EPS has ranged from a loss of US$0.02 to a loss of US$0.55. These...
NYSE:DNA
NYSE:DNALife Sciences

Ginkgo Bioworks Q4 Loss Profile Reinforces Bearish Narratives On Cash Burn And Profit Timing

Ginkgo Bioworks Holdings (DNA) has just wrapped up FY 2025 with Q4 revenue of about US$33.4 million and a basic EPS loss of US$1.41, while net income excluding extra items came in at a loss of US$80.8 million. Over recent quarters the company has seen revenue move from US$89.0 million in Q3 2024 to US$48.3 million in Q1 2025, US$49.6 million in Q2, US$38.8 million in Q3 and US$33.4 million in Q4. This has come alongside basic EPS losses ranging between US$1.08 and US$2.00. Together, these...
NasdaqGS:CAI
NasdaqGS:CAIBiotechs

Caris Life Sciences (CAI) Q4 Profitability Turnaround Tests Skeptical Earnings Narratives

Caris Life Sciences (CAI) closed out FY 2025 with Q4 revenue of US$292.9 million and basic EPS of US$0.29, alongside net income of US$82.0 million. Over the past six reported quarters, the company has seen revenue move from US$129.9 million in Q4 2024 to US$292.9 million in Q4 2025. Over the same period, basic EPS has ranged from a loss of US$7.97 in Q2 2025 to a profit of US$0.29 in the latest quarter. This sets up a story in which improving margins and the quality of those earnings are...
NYSE:SRE
NYSE:SREIntegrated Utilities

Sempra (SRE) Margin Drop To 13.2% Tests Bullish Growth And Valuation Narratives

Latest Earnings Snapshot and What Comes Next Sempra (SRE) just closed out FY 2025 with fourth quarter revenue of US$3,749 million and basic EPS of US$0.54, while trailing twelve month revenue stood at US$13.7 billion and basic EPS at US$2.77. This sets a baseline for how the market may view this update. The company reported quarterly revenue of US$3,758 million in Q4 2024 and US$3,749 million in Q4 2025, while basic EPS moved from US$1.05 to US$0.54 over the same period. As a result,...
NasdaqCM:ASUR
NasdaqCM:ASURProfessional Services

Asure Software Q4 Profit Challenges Ongoing Unprofitability Narrative For Asure Software (ASUR)

Asure Software (ASUR) closed out FY 2025 with Q4 revenue of US$39.3 million and basic EPS of US$0.03, set against a trailing twelve month net loss of US$13.1 million and basic EPS of a US$0.48 loss. Over recent quarters the company has seen revenue move from US$29.3 million in Q3 2024 to US$30.8 million in Q4 2024 and then to US$39.3 million in Q4 2025, while quarterly basic EPS has shifted from a loss of US$0.12 in Q4 2024 to a profit of US$0.03 in Q4 2025. For investors, that mix of growing...
NYSE:APO
NYSE:APODiversified Financial

Apollo Global Management Margins Slip To 11% Challenging Bullish Earnings Narratives

Apollo Global Management FY 2025 earnings snapshot Apollo Global Management (APO) closed out FY 2025 with fourth quarter revenue of about US$9.8b and basic EPS of US$1.44, anchored by net income of US$854m. This highlights how the firm is converting a large top line into bottom line results. The company reported quarterly revenue of US$5.2b in Q4 FY 2024 and US$9.8b in Q4 FY 2025, while basic EPS moved from US$2.94 to US$1.44 over the same period. Investors are likely to weigh the revenue...
NasdaqGS:CGON
NasdaqGS:CGONBiotechs

The Bull Case For CG Oncology (CGON) Could Change Following Surging Revenue And Deeper 2025 Losses – Learn Why

CG Oncology, Inc. reported past full-year 2025 results, with revenue rising to US$4.04 million from US$1.14 million and net loss widening to US$161 million from US$88.04 million, alongside confirmation that its leadership presented at the TD Cowen 46th Annual Health Care Conference earlier this month. The combination of higher revenue with a larger loss highlights the company’s ongoing investment in its business model and cost structure, which investors may weigh against its early-stage...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

Viatris (VTRS) Quarterly Loss Of US$340.1 Million Tests Profitability Turnaround Narrative

Recent results put Viatris's profitability under the microscope Viatris (VTRS) has just posted its FY 2025 numbers, with fourth quarter revenue of US$3,703.6 million and a basic EPS loss of US$0.30, while trailing twelve month revenue came in at US$14.3 billion alongside a basic EPS loss of US$3.00. Over recent periods, the company has seen quarterly revenue move from US$3,528.1 million in Q4 2024 to US$3,703.6 million in Q4 2025, with basic EPS shifting from a loss of US$0.43 to a loss of...
NYSE:RKT
NYSE:RKTDiversified Financial

Rocket Companies (RKT) Returns To Q4 Profit But Trailing Loss Tests Bullish Narratives

Rocket Companies FY 2025 Results: Revenue Rebound but Profitability Still Tight Rocket Companies (RKT) has just posted its FY 2025 numbers with Q4 revenue of US$2.8 billion and basic EPS of US$0.02, setting a very different tone from earlier quarters in the year that were in loss territory. The company has seen quarterly revenue move from US$1.1 billion in Q1 2025 to US$1.7 billion in Q3 and then to US$2.8 billion in Q4. EPS shifted from losses of US$0.07 in Q1 and US$0.06 in Q3 to a small...
NYSE:PAR
NYSE:PARSoftware

PAR Technology (PAR) Q4 Losses Around US$21 Million Reinforce Profitability Concerns

PAR Technology (PAR) closed out FY 2025 with Q4 revenue of US$120.1 million and a basic EPS loss of US$0.51, while trailing twelve month revenue sat at US$455.5 million alongside a basic EPS loss of US$2.09. Over recent quarters, the company has seen revenue move from US$96.8 million in Q3 2024 to US$105.0 million in Q4 2024, then to US$103.9 million in Q1 2025, US$112.4 million in Q2 2025, US$119.2 million in Q3 2025 and US$120.1 million in Q4 2025, as quarterly basic EPS losses ranged...
NasdaqGS:DH
NasdaqGS:DHHealthcare Services

Definitive Healthcare (DH) Quarterly Loss Highlights Ongoing Profitability Gap Despite Stable Revenue

Definitive Healthcare (DH) has wrapped up FY 2025 with Q4 revenue of US$61.5 million and a basic EPS loss of US$0.09, alongside a trailing twelve month loss of US$1.30 per share on US$241.5 million of revenue. Over recent periods, the company has reported quarterly revenue between US$59.2 million and US$62.7 million, while basic EPS has ranged from a loss of US$0.07 to a loss of US$1.12. For investors, the latest results keep attention on when margins might begin to close the gap between a...
NYSE:MTZ
NYSE:MTZConstruction

MasTec (MTZ) EPS Rebound Challenges Skeptical Narratives On Thin Margins And Premium P/E

MasTec (MTZ) has wrapped up FY 2025 with fourth quarter revenue of US$3.9b, basic EPS of US$1.83 and net income excluding extraordinary items of US$142.7m, capping a year in which trailing twelve month revenue reached US$14.3b, EPS came in at US$5.12 and net income was US$399m. Over the past six reported quarters, revenue has ranged from US$2.8b in Q1 2025 to US$4.0b in Q3 2025, while quarterly basic EPS moved between US$0.13 and US$2.07, giving investors a clearer view of how the earnings...
NYSE:NATL
NYSE:NATLDiversified Financial

NCR Atleos (NATL) Margin Rebound To 3.7% Tests Bullish Recurring Revenue Narrative

NCR Atleos (NATL) just wrapped up FY 2025 with Q4 revenue of US$1.2b and basic EPS of US$1.13, alongside net income of US$83 million. The trailing twelve month line shows total revenue of US$4.4b and basic EPS of US$2.20. The company has seen quarterly revenue move from US$979 million in Q1 2025 to US$1.2b in Q4 2025, with basic EPS over those quarters ranging from US$0.21 to US$1.13. Trailing twelve month basic EPS shifted from US$1.26 in Q4 2024 to US$2.20 in Q4 2025. Together, these...
NYSE:MAA
NYSE:MAAResidential REITs

The Bull Case For Mid-America Apartment Communities (MAA) Could Change Following New 2033 Notes And Redevelopment Push

Mid-America Apartment Communities recently issued US$200,000,000 of 4.650% senior unsecured notes due 2033 and outlined plans to allocate proceeds toward repaying commercial paper borrowings and funding potential acquisitions, development, and redevelopment projects, while also preparing to discuss its outlook at the 2026 Citi Global Property CEO Conference. Alongside this new debt issuance, management’s increased capital spending plans and active US$932.00 million development pipeline...
NYSE:BIO
NYSE:BIOLife Sciences

Is It Time To Reconsider Bio-Rad Laboratories (BIO) After Its Prolonged Share Price Slump

If you are wondering whether Bio-Rad Laboratories is offering good value at around US$278.44 per share, this article walks through what the current price might be implying about the business. The stock has had a mixed run, with a 2.6% gain over the last 7 days, a 7.1% decline over 30 days, an 8.8% decline year to date, a 5.0% return over 1 year, a 44.6% decline over 3 years, and a 51.0% decline over 5 years. These ups and downs have kept valuation in focus for many investors, especially as...
NYSE:BETA
NYSE:BETAAerospace & Defense

Dean Kamen Exit Puts Spotlight On BETA Governance And Valuation

Dean Kamen has resigned from BETA Technologies’ (NYSE:BETA) Board of Directors following questions about his past associations. Kamen stepped down to avoid potential distractions for the company as scrutiny of his previous dealings with Jeffrey Epstein increased. The resignation draws attention to BETA Technologies’ board composition and broader governance practices at a time when investors are closely watching leadership and oversight. BETA Technologies, traded as NYSE:BETA, focuses on...
NYSE:CPK
NYSE:CPKGas Utilities

Chesapeake Utilities (CPK) Earnings Growth Outpaces Modest Revenue Trends Reinforcing Profitability Narrative

Chesapeake Utilities (CPK) has wrapped up FY 2025 with fourth quarter revenue of US$258.9 million and basic EPS of US$1.94, alongside full year trailing twelve month revenue of US$930 million and EPS of US$6.00. Over recent periods, the company has seen quarterly revenue move from US$215.0 million and EPS of US$1.60 in Q4 2024 to US$298.7 million and EPS of US$2.22 in Q1 2025, before landing at the latest Q4 2025 figures, with trailing net income reaching US$140.3 million. With earnings...
NasdaqGS:CARG
NasdaqGS:CARGInteractive Media and Services

Assessing CarGurus (CARG) Valuation After Strong 2025 Results Guidance And Buybacks

CarGurus (CARG) is back in focus after reporting Q4 and full year 2025 results, issuing 2026 revenue guidance, and outlining fresh share repurchase activity that together give investors new information to assess the stock. See our latest analysis for CarGurus. Despite the fresh earnings, guidance and new buyback authorization, recent share price performance has been soft, with a 30 day share price return of 8.08% and a year to date share price return of 18.41%. At the same time, the 3 year...
NYSE:VIPS
NYSE:VIPSMultiline Retail

Vipshop Holdings NYSE VIPS Margin Dip To 6.8% Tests Bullish Earnings Narratives

Vipshop Holdings (NYSE:VIPS) closed out FY 2025 with fourth quarter revenue of C¥32.5b and basic EPS of C¥5.29, while trailing 12 month revenue stood at C¥105.9b and EPS at C¥14.47. Over the last six reported quarters, the company has seen quarterly revenue range from C¥20.7b to C¥33.2b alongside basic EPS between C¥2.00 and C¥5.29. This gives you a clear view of how top line scale and per share profitability have moved together into this latest print. Taken together with a net margin last...